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Abstract
Obesity and high saturated fat intake increase the risk of heart failure and arrhythmias. The
molecular mechanisms are poorly understood. We hypothesized that physiologic levels of
saturated fat could increase mitochondrial reactive oxygen species (ROS) in cardiomyo-
cytes, leading to abnormalities of calcium homeostasis and mitochondrial function. We
investigated the effect of saturated fat on mitochondrial function and calcium homeostasis
in isolated ventricular myocytes. The saturated fatty acid palmitate causes a decrease in
mitochondrial respiration in cardiomyocytes. Palmitate, but not the monounsaturated fatty
acid oleate, causes an increase in both total cellular ROS and mitochondrial ROS. Palmitate
depolarizes the mitochondrial inner membrane and causes mitochondrial calcium overload
by increasing sarcoplasmic reticulum calcium leak. Inhibitors of PKC or NOX2 prevent mito-
chondrial dysfunction and the increase in ROS, demonstrating that PKC-NOX2 activation is
also required for amplification of palmitate induced-ROS. Cardiomyocytes from mice with
genetic deletion of NOX2 do not have palmitate-induced ROS or mitochondrial dysfunction.
We conclude that palmitate induces mitochondrial ROS that is amplified by NOX2, causing
greater mitochondrial ROS generation and partial depolarization of the mitochondrial inner
membrane. The abnormal sarcoplasmic reticulum calcium leak caused by palmitate could
promote arrhythmia and heart failure. NOX2 inhibition is a potential therapy for heart dis-
ease caused by diabetes or obesity.
Introduction
Excessive lipid accumulation is found in cardiomyocytes from obese and diabetic patients, and
is believed to contribute to heart failure and arrhythmia [1–4]. Obesity and diabetes increase
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the risk of heart failure, independently of coronary atherosclerosis [5–7]. Obese and diabetic
patients are at increased risk for several types of arrhythmia, including atrial fibrillation [8, 9].
More importantly, several epidemiologic studies have shown that obese patients have approxi-
mately twice the risk of sudden cardiac death, and diabetics three times the risk, as age matched
controls [10–13]. The increased risk of sudden cardiac death is greater than the increased risk
of myocardial infarction, suggesting that arrhythmic events are increased more than coronary
events in obese and diabetic patients. Human epidemiology studies show that higher saturated
fat intake leads to an increased risk of sudden cardiac death, [14–17], suggesting that the effects
of saturated fat on the heart may be more important than obesity per se.
Reactive oxygen species (ROS) are a mechanistic link between lipid metabolism and cardio-
vascular pathology [18–20]. Mild, transient increases in cardiac ROS may be involved in adap-
tive processes, but it is postulated that long-term increases in cardiac ROS are detrimental [21].
There are several sources of ROS in cardiomyocytes, including NAPDH oxidase (NOX), nitric
oxide synthase (NOS), and mitochondria. Mitochondria are a major source of ROS in myo-
cytes [22]. A high-fat diet increases mitochondrial ROS in skeletal muscle [23] and decreases
cardiac efficiency, defined as cardiac work divided by oxygen consumption [24]. However, the
molecular mechanisms are not well understood, despite the fact that isolated mitochondria
have been studied intensely for decades. Experiments using isolated cardiac mitochondria
exposed to saturated fatty acids have given conflicting results regarding ROS generation [25,
26]. There is relatively little data regarding the effects of fatty acid metabolism on ROS and
mitochondrial function in intact cardiomyocytes. Using intact cardiomyocytes has the advan-
tage of preserving signaling pathways and interactions between mitochondria and other subcel-
lular compartments.
In order to study the effects of fatty acids on cardiac metabolism, we used palmitate, because
it is one of the most prevalent saturated fats in the bloodstream of mammals [27]. We used the
monounsaturated fatty acid oleate (the principle component of olive oil) as a control, which is
thought to be benign based on nutritional epidemiology [28]. We hypothesized that physio-
logic levels of saturated fatty acid could increase mitochondrial ROS in cardiomyocytes, leading
to abnormalities of calcium homeostasis and mitochondrial function.
Materials and Methods
Materials
Oleate and palmitate were purchased from Sigma and dissolved in sterile water to make a 10
mM solution with 10% fatty-acid free BSA (Sigma), then diluted to final concentration 200 μM
in media. Mito-TEMPO was purchased from Enzo Life Science. The NOX2 inhibitor peptide
gp91-ds tat was purchased from Anaspec, Inc. Mitosox red, Rhod2-AM, and TMRM were pur-
chased from Life Technologies. Other chemicals were purchased from Sigma. The anti-PKCal-
pha antibody was purchased from Santa Cruz. The anti-KDEL primary antibody was
purchased from Thermo Scientific.
Animal care and cardiomyocyte isolation
Animal protocols were approved by the Columbia University Institutional Animal Care and
Use Committee and were carried out in accordance with the NIH guidelines for the care and
use of laboratory animals. Wild type (WT) C57BL and B6.129S-Cybbtm1Din/J (NOX2 KO) mice
were purchased from Jackson labs. Mice were 9–12 weeks old at the time of experiments. Isola-
tion of cardiomyocytes was performed as previously described using isoflurane for anesthesia
[2].
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Fatty acid treatment and measurements of ROS, mitochondrial calcium,
and mitochondria depolarization
We used a physiologic concentrations of fatty acids, (200 μM) bound to bovine serum albumin
(BSA) [29]. After fatty acid treatment, isolated cardiomyocytes were divided into aliquots. To
measure total cellular ROS, cells were loaded with the fluorescent dye 2’, 7’-Dichlorofluorescin
diacetate (H2DCF-DA) (25 μM). Once it enters the cell, H2DCF-DA is converted by oxidation
to DCF, which is fluorescent, and this is widely used as a measure of general oxidative stress
[30]. To measure mitochondrial ROS, Mitosox Red (5 μM), was used to analyze mitochondrial
superoxide generation. Cells were incubated with DCF or mitosox red for 30 minutes in the
dark. Excess DCF or Mitosox Red was removed with two washes of BSA solution. DCF fluores-
cence was recorded at excitation/emission wavelengths: 488/532 nm whereas MitoSOX Red
was recorded at 525 (excitation) and 620 nm (emission). To assess the changes in mitochon-
drial membrane potential, cardiomyocytes were stained with 1nM tetramethylrhodamine
methyl (TMRM) ester for 30 minutes and recorded at 543 nm (excitation)/590 nm (emission).
TMRM preferentially accumulates in mitochondria due to its positive charge. As mitochondria
are depolarized, they trap less TMRM, and so the signal is proportional to the inner membrane
potential of the mitochondria. To determine the changes in mitochondrial calcium in living
cells, cardiomyocytes were loaded with 10 μMRhod 2-AM and incubated for 30 minutes fol-
lowed by a one-hour washout with cytosolic quenching using manganese, to produce specific
mitochondrial calcium signal [31]. Rhod2AM fluorescence was measured at 552 nm (excita-
tion)/ 581 nm (emission). Cells were loaded onto a 96-well in triplicate, plated at 2000 cells/
well, and fluorescence was measured with a Tecan Infinite 200 plate reader. NADPH-
dependent superoxide production was measured in LV homogenates using lucigenin enhanced
chemiluminescence as previously described [32].
Cell culture
H9c2 cells were purchased from ATCC and cultured in DMEM (Life Technologies) supple-
mented with 10% FBS (Atlanta Biologicals) and with penicillin and streptomycin (Fisher).
Respirometry
Oxygen consumption rate and extra-cellular acidification rate were measured in cardiomyo-
cytes with a XF24 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA). Car-
diomyocytes were seeded in XF 24-well cell culture microplates at a density of 3000 cells/well.
The wells were pre-coated with laminin to improve adherence. Cells were then treated with
200 μM of BSA-conjugated fatty acid: palmitate, oleate or BSA vehicle control. After replacing
the growth medium with 525 μL of bicarbonate-free DMEM pre-warmed at 37°, cells were
incubated for 30 min before starting the assay procedure. After baseline measurements, ATP
synthase was inhibited with oligomycin, and then maximal respiration was stimulated with the
ionophore carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP). Finally, antimycin-
A and rotenone were added to inhibit the mitochondrial electron transport chain in order to
measure non-mitochondrial oxygen consumption. The concentrations used are as follows: oli-
gomycin (4 μM), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 0.25 μM),
and rotenone plus antimycin A (1 μM each). We determined the best concentration if FCCP
for cardiomyocytes by conducting a series of titration experiments at the beginning of the proj-
ect. Coupling efficiency (defined as the reduction in oxygen consumption after oligomycin
injection) is the fraction of basal mitochondrial oxygen consumption used for ATP synthesis.
Cell respiratory control ratio is the ratio of the uncoupled oxygen consumption rate to the
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oxygen consumption rate with oligomycin. Non-mitochondrial respiration was subtracted
from all rates.
Respiratory chain enzyme activity assessment
Biochemical activities of COX, NADH-cytochrome c reductase (complex I+III), succinate-
cytochrome c reductase (complex II+III), NADH-CoQ reductase (complex I), succinate dehy-
drogenase (complex II) and citrate synthase were assayed with spectrophotometry as previ-
ously described [33]. CoQ-cytochrome c reductase (complex III) was measured as described
previously [34]. Respiratory chain enzyme activity values were normalized to protein
concentration.
Preparation of protein extracts and western blot analysis
For total protein extract preparation, mouse ventricular samples or cell pellets were homoge-
nized in RIPA buffer (Thermo Scientific) containing protease and phosphatase inhibitors
(Roche). For membrane extract, ventricular samples were homogenized in membrane buffer
(20 mM Tris-HCl pH 7.2, 2 mM EDTA, 2 mM EGTA, 50 mMNaF, and 6 mMmercaptoetha-
nol) containing protease and phosphatase inhibitors (Roche). Samples were spun at 33, 000
rpm for 30 minutes at 2°C. The pellet was suspended in buffer containing 1% SDS and incu-
bated on ice for 30 minutes. Samples were subjected to 10% SDS-PAGE. Proteins were trans-
ferred onto a nitrocellulose membrane and probed with the indicated antibodies. PKCalpha
primary antibody was used at a 1:1000 dilution. The blots were reprobed with KDEL primary
antibody for normalization. Alkaline phosphatase-conjugated goat anti-rabbit IgG (Santa
Cruz) was used as secondary antibody, and immunoreactive bands were detected with ECL
solution (Thermo Scientific), according to the manufacturer’s instructions. Quantification was
performed using Image J software.
Spark recording and analysis
Sparks were recorded with a Leica SP2 confocal microscope equipped with a 63X 1.4 NA objec-
tive. Cardiomyocytes were loaded with fluo-4 (5 mM, 10 min), in modified Tyrode’s solution
containing 1 mM calcium. Line scan images were recorded with Leica TCS software and quan-
tified with the Sparkmaster plugin of ImageJ, created by Donald Bers.
Confocal microscopy
Confocal imaging was performed on a Nikon A1 laser scanning confocal attachment on an
Eclipse Ti microscope stand (Nikon Instruments, Melville, NY) using a 40x/1.3 Plan Fluor oil-
immersion objective. The confocal pinhole was set at 1 Airy unit, to produce an optical section
of approximately 0.5 um. MitoTracker Green and MitoSOX Red (Life Technologies, Grand
Island, NY) were imaged sequentially and emission was collected with standard fluorescein
and rhodamine emission filters. Single optical sections were collected for each cell shown.
Statistical analysis
Results are presented as mean ±SEM. The unpaired t-test was used for comparisons of two
means; a 2-tailed value of P< 0.05 was considered statistically significant. For groups of 2 or
more ANOVA was used with post-hoc testing (Prism v5, GraphPad Software).
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PLOS ONE | DOI:10.1371/journal.pone.0145750 January 12, 2016 4 / 17
Results
The saturated fat palmitate causes a decrease in mitochondrial
respiration in cardiomyocytes
Wemeasured the effect of fatty acids on mitochondrial respiration using isolated adult mouse
ventricular myocytes fromWTmice. We treated cardiomyocytes with palmitate, oleate, or
BSA (vehicle control) for 3 hours before flux analysis. We quantified respiration by measuring
oxygen consumption rate and estimated glycolysis by extracellular acidification rate. Palmitate
had a strong inhibitory effect on maximal respiration (Fig 1A). Oleate had an intermediate
effect. Palmitate also caused a small reduction in glycolysis, perhaps as compensation for using
fatty acid as a fuel source (Fig 1B). Additional experiments were performed to evaluate mito-
chondrial enzyme activity, using lysates made from cardiomyocytes after exposure to oleate or
palmitate. Palmitate caused a significant reduction in the activity of mitochondrial complex III
of the electron transport chain (Fig 1D).
Fig 1. Palmitate causes a decrease in mitochondrial oxygen consumption in cardiomyocytes. A. Oxygen consumption rate is decreased by palmitate.
B. Extracellular acidification rate from the same experiment. Data fromWT cardiomyocytes. Measurements from three time-points were obtained under each
condition, using triplicate wells. b = baseline, o = oligomycin, F = FCCP, AA = antimycin-A and rotenone. C. Respiratory control ratio is reduced significantly
by palmitate. D. Electron transport chain complex III activity is significantly reduced by palmitate. Units are nanomoles substrate utilized/min/mg protein. The
means of all graphs are significantly different by ANOVA, * = sig different from control by post-hoc test.
doi:10.1371/journal.pone.0145750.g001
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Palmitate increases mitochondrial ROS in cardiomyocytes
Next, we quantified palmitate-induced ROS production in intact cardiomyocytes. Cardiomyo-
cytes were treated with a physiologic dose of palmitate or oleate for two or four hours and then
stained with the ROS indicators DCF and mitosox red (a specific indicator of mitochondrial
ROS). At both time-points, palmitate significantly increased total cellular ROS, as indicated by
DCF signal (Fig 2A). Palmitate also caused a significant increase in mitochondrial ROS (Fig 2B
and 2E). Oleate did not cause a significant increase in total or mitochondrial ROS. The fact
that total ROS is increased at an earlier time point than mitochondrial ROS suggests that non-
mitochondrial sources of ROS have an important contribution to total ROS induced by satu-
rated fat. These results show that a shorter exposure to saturated fat may be harmless, but lon-
ger durations of exposure increase ROS. Human studies have shown that high fat diet causes
persistent elevations of serum fatty acids (longer than 4 hours) [35], supporting the physiologic
relevance of this duration of treatment.
To determine if mitochondrial use of fatty acids as a metabolic substrate was required for
the increase in ROS, we used a pharmacologic approach. Both etomoxir, an inhibitor of
Fig 2. Cardiomyocytes treated with palmitate have increased total andmitochondrial ROS. A.
Representative experiment done with cardiomyocytes in triplicate, height is DCF fluorescence minus
background, in live cells, expressed in arbitrary units, mean + SEM. Palmitate, but not oleate, increases ROS
significantly. PA = palmitate 200 μM, OA = oleate 200 μM, B. Cardiomyocytes from the same experiment
using mitosox red readout to indicate mitochondrial ROS. C. Inhibition of mitochondrial lipid uptake or beta-
oxidation prevents the increase in ROS. ETO = etomoxir 200 μM, TMZ = trimetazidine 10 μM, MT = mito-
TEMPO, 20 μM. D. Cardiomyocytes from the same experiment using mitosox red readout. For all panels,
means are significantly different by ANOVA, * = sig different from control by post-hoc test. E. Confocal
images of live isolated cardiomyocytes after control and palmitate treatment. Cells were stained with mitosox
red and counter-stained with mitotracker green.
doi:10.1371/journal.pone.0145750.g002
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mitochondrial fatty-acid uptake, and trimetazidine, an inhibitor of fatty acid beta-oxidation,
prevented the increase in total cellular and mitochondrial ROS (Fig 2C and 2D). In addition,
mito-tempo, a mitochondrial targeted anti-oxidant, eliminated the increase in total ROS. Mito-
tempo suppresses the increase in total ROS more effectively than it suppresses the increase in
mitochondrial ROS. This suggests that the large increase in total cellular ROS at the later time-
point may be amplified by a threshold level of mitochondrial ROS.
To verify these findings, and to demonstrate that the palmitate effect is not a consequence
of the isolation procedure, we repeated these experiments using the cardiomyoblast cell line
H9c2. These experiments also showed increased ROS after exposure to palmitate (S1 file).
Since high doses of palmitate can cause apoptosis in some cell types, cell death was evaluated
by trypan blue. At these doses and time points, palmitate did not cause cell death. There was a
non-significant trend towards increased cell death with concentrations of palmitate greater
than 200 μM (S1 file).
Palmitate depolarizes the mitochondrial inner membrane and causes
mitochondrial calcium overload
To better characterize the mitochondrial abnormalities induced by palmitate, we quantified the
mitochondrial inner membrane potential using TMRM [36]. Palmitate causes a significant
reduction in mitochondrial membrane potential in cardiomyocytes and H9c2 cells, indicating
mitochondrial damage or dysfunction (Fig 3A and 3C). Dantrolene, a specific inhibitor of rya-
nodine receptor channels (RyR), prevented the decrease in mitochondrial membrane potential.
Since RyR channels release calcium from the sarcoplasmic reticulum, this indicates that palmi-
tate-induced ROS leads to increased calcium release from RyR channels, which enhances mito-
chondrial dysfunction. We verified this mechanism by quantifying mitochondrial calcium
levels during palmitate treatment, which demonstrated that palmitate causes a significant
increase in mitochondrial calcium (Fig 3D).
To confirm that mitochondrial calcium overload occurs by RyR-mediated calcium release
from the sarcoplasmic reticulum, we quantified spontaneous calcium release events from the
sarcoplasmic reticulum, in the form of sparks. Treatment of WT cardiomyocytes with palmi-
tate caused a significant increase in spark frequency (Fig 3E and 3F). Our data show that palmi-
tate exposure is sufficient to increase calcium leak from the sarcoplasmic reticulum, causing
mitochondrial calcium overload in cardiomyocytes, a novel finding.
Palmitate induced ROS production is inhibited by blocking protein
kinase C or NAPDH oxidase
Lipids are known to activate conventional and novel PKC isoforms. To measure PKC activa-
tion, cardiomyocytes were treated with palmitate and oleate, and then harvested for membrane
preparation western blots. PKCalpha was activated by palmitate, but not by oleate (Fig 4A
and 4B). To determine if palmitate-induced ROS requires PKC activation, we inhibited PKC
with two different pharmacologic inhibitors, Go6983 (a broad-spectrum PKC inhibitor)
and LY333531 (aka ruboxistaurin, thought to be more specific for PKCalpha and beta [37]).
Both PKC inhibitors resulted in a significant decrease in total cellular and mitochondrial
ROS, demonstrating that PKC activation is necessary for palmitate-induced ROS generation
(Fig 4C and 4D). Further, the PKC inhibitors also prevented the decrease in mitochondrial
inner membrane potential and the mitochondrial calcium overload induced by palmitate (Fig
4E and 4F).
In other cells types, PKC activation increases ROS by activating NOX2 [38]. We found that
the NOX2 inhibitor apocynin was effective at preventing the increase in total cellular and
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mitochondrial ROS in cardiomyocytes (S2 file). We also used a NOX2 inhibitor peptide,
gp91ds-tat, to ensure specificity. The peptide inhibitor prevented the increase in ROS as
detected by DCF and mitosox red (Fig 4C and 4D). The peptide inhibitor also prevented mito-
chondrial dysfunction, by preventing depolarization and calcium overload (Fig 4E and 4F).
L-NAME, a specific inhibitor of nitric oxide synthase, which is another source of ROS in cardi-
omyocytes, had minimal effect. Thus, NOX2 activation is required for the palmitate-induced
increase in ROS, and nitric oxide synthase is not involved. We also repeated these experiments
using the H9c2 cell line. These results were consistent (S3 file). This shows that palmitate-
induced mitochondrial dysfunction requires both PKC and NOX2 activation. In cardiomyo-
cytes, it appears that NOX2 activation amplifies mitochondrial ROS production in a feed-for-
ward cycle, an example of the phenomenon known as ROS induced ROS release (RIRR) [39].
To improve our understanding of the mechanisms involved in NOX2 activation, we used
the lucigenin assay to measure NOX2 activity [32]. Lucigenin consistently showed a significant
increase in NOX2 activity after two hours of palmitate treatment (Fig 4I and 4J). The increase
in NOX2 activity was prevented by inhibition of mitochondrial uptake of fatty acids using eto-
moxir, and also by the PKC inhibitors, Go6983 and LY333531. This is consistent with a
Fig 3. Palmitate depolarizes the mitochondrial inner membrane potential and causesmitochondrial calcium overload from increased sparks. A.
Representative experiment done with cardiomyocytes in triplicate, height is TMRM fluorescence minus background, in live cells, expressed in arbitrary units,
mean + SEM. PA = palmitate 200 μM. B. Dantrolene prevents the loss of inner membrane potential. Dan = dantrolene 1 μM. C. Similar experiment using
H9c2 cells and TMRM readout. D. Cardiomyocytes with Rhod2AM readout indicating mitochondrial calcium. For all panels, means are significantly different
by ANOVA, * = sig different from control by post-hoc test. E. Representative line-scan sparks experiments from cardiomyocytes; height is spark amplitude,
over time. F. Graph of sparks, normalized to control, n = 10–11, * = p<0.05.
doi:10.1371/journal.pone.0145750.g003
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mechanism where mitochondrial uptake of palmitate causes a small initial increase in mito-
chondrial ROS, which activates PKC, which in turn activates NOX2.
PKC-induced mitochondrial ROS is generated by NOX2 in
cardiomyocytes
To determine how PKC activation causes ROS generation in cardiomyocytes, we treated cardi-
omyocytes with the PKC activator PMA, which is known to increase ROS in several cell types.
After one hour, PMA caused a significant increase in total ROS and mitochondrial ROS (Fig
5A and 5B). Pharmacologic inhibition of NOX2 was almost as effective in preventing the
Fig 4. Palmitate activates PKC, and palmitate-induced ROS production is inhibited by blocking PKC or NOX2. A. Western blot frommembrane
preparation, arbitrary units, H9c2 cells. KDEL is a loading control for sarcoplasmic reticulum. B. Graph of membrane protein band quantification from panel A,
expressed in arbitrary units. C. Western blot from cytosolic fraction, arbitrary units, H9c2 cells. D. Graph of membrane protein band quantification from panel
C. No significant difference by ANOVA. E. Representative experiment done with cardiomyocytes in triplicate, height is DCF fluorescence minus background,
in live cells, mean + SEM. F. Cardiomyocytes from the same experiment using mitosox red readout. G. Cardiomyocytes from the same experiment using
TMRM signal. H. Cardiomyocytes from the same experiment using Rhod2 signal. I. Time course of NOX2 activation with oleate or palmitate, using H9c2
cells, expressed in arbitrary units. J. Etomoxir and PKC inhibitors prevent NOX2 activation, representative experiment using H9c2 cells. For all panels except
D, means are significantly different by ANOVA, * = sig different from control by Dunnett post-hoc test. PA = palmitate 200 μM, OA = oleate 200 μM,
ETO = etomoxir 200 gp = gp91ds peptide 50 μM, Ln = L-NAME 10 μM, Go = Go6983 5 μM, LY = LY333531 50 nM.
doi:10.1371/journal.pone.0145750.g004
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increase in DCF signal as PKC inhibition, demonstrating that PKC activation increases total
cellular ROS predominantly via NOX2 in cardiomyocytes. PMA also caused depolarization of
the mitochondrial inner membrane potential and mitochondrial calcium overload, and these
abnormalities are partially prevented by the NOX2 inhibitor (Fig 5C and 5D). This shows that
NOX2 activation is a major mechanism of PKC-activation induced ROS and mitochondrial
dysfunction in cardiomyocytes.
Additional experiments showed that mitotempo improved the abnormalities caused by
PMA (S4 file). This is consistent with a mechanism where mitochondrial ROS amplifies NOX2
ROS production in a feed-forward cycle.
Increasing sarcoplasmic reticulum calcium leak is sufficient to generate
mitochondrial ROS that is amplified by NOX2, leading to greater
mitochondrial dysfunction
To determine if increasing RyR calcium release is sufficient to cause mitochondrial depolariza-
tion and ROS, we treated cardiomyocytes with cresol (aka 4-chloro-3-methylphenol) which is
a well-described activator of RyR channels [40]. At moderate doses, cresol caused a significant
increase in both total ROS and mitochondrial ROS (Fig 5E and 5F). Mitochondrial inner mem-
brane potential was decreased by increased RyR leak (Fig 5G). These abnormalities were par-
tially improved by the NOX2 inhibitor peptide. We confirmed that cresol caused
mitochondrial calcium overload, which was improved by the NOX2 inhibitor peptide (Fig 5H).
Thus, even in this relatively pure case of sarcoplasmic reticulum calcium leak, NOX2 activation
Fig 5. NOX2 inhibition reduces PMA-induced and cresol-induced ROS. A. Representative PMA experiment done with cardiomyocytes in triplicate,
height is DCF fluorescence minus background, in live cells, expressed in arbitrary units, mean + SEM. B. PMA experiment using mitosox red signal. C. PMA
experiment using TMRM signal. The NOX2 inhibitor and PKC inhibitors reduce depolarization. D. PMA experiment using Rhod2 signal. The NOX2 inhibitor
and PKC inhibitors reduce calcium overload. E,F. Cresol increases total ROS and mitochondrial ROS. G. Cresol depolarized the mitochondrial inner
membrane. H. Cresol increases mitochondrial calcium. For all panels, means are significantly different by ANOVA, * = sig different from control by post-hoc
test, # = sig different from PMA by post-hoc test. PMA 100 nM, gp = gp91ds peptide 50 μM, Go = Go6983 5 μM, LY = LY333531 50 nM, Cre = cresol 1 or
3 μM.
doi:10.1371/journal.pone.0145750.g005
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amplifies mitochondrial ROS, causing worse mitochondrial depolarization and calcium
overload.
NOX2 KO cardiomyocytes do not generate palmitate-induced ROS, or
PKC-induced ROS
To confirm the specificity of our findings with apocynin and the NOX2 inhibitor peptide, we
pursued a genetic approach. NOX2 is composed of p47phox (which is also a component of
NOX1), the catalytic protein gp91, and several regulatory subunits. We used isolated cardio-
myocytes from adult male NOX2 KOmice, and determined that palmitate does not increase
total or mitochondrial ROS in NOX2 KO cardiomyocytes (Fig 6A and 6B). Further, NOX2 KO
cardiomyocytes did not have mitochondrial depolarization or mitochondrial calcium overload
after palmitate treatment. This proves that NOX2 activity is required for palmitate-induced
ROS generation and mitochondrial dysfunction. Treatment of the NOX2 KO cardiomyocytes
with PMA, to activate endogenous PKC, did not result in ROS, mitochondrial depolarization
or mitochondrial calcium overload. This is additional evidence that PKC generates ROS pre-
dominantly by activating NOX2 in cardiomyocytes. As a positive control, cresol still caused
an increase in ROS and depolarized the mitochondrial inner membrane in NOX2 KO cardio-
myocytes, though the magnitude of the effect was less than the abnormalities induced in WT
cardiomyocytes. This is consistent with increased RyR leak causing calcium overload of mito-
chondria, leading to mild mitochondrial ROS generation that is then amplified by NOX2 acti-
vation in WT cardiomyocytes.
Blockade of the mitochondrial electron transport chain causes ROS and
mitochondrial inner membrane depolarization that is similar to palmitate
Fatty acids are thought to act as mitochondrial uncouplers, but have also been postulated to
block the mitochondrial electron transport chain [26, 41–43]. To determine if the observed pal-
mitate-induced abnormalities are consistent with the block mechanism, we performed a series
of experiments with antimycin-A, which selectively blocks complex III of the electron transport
chain. Escalating doses of antimycin-A caused a step-wise decrease in the mitochondrial inner
membrane potential and resulted in a significant increase in total ROS and mitochondrial ROS
in cardiomyocytes (Fig 7). The NOX2 inhibitor peptide prevented the increase in total ROS,
and blunted the increase in mitochondrial ROS, without having much effect on the reduction
Fig 6. NOX2 KO cardiomyocytes do not have an increase in ROS in response to palmitate or PKC activation. A. Representative experiment done with
cardiomyocytes in triplicate, height is DCF fluorescence minus background, in live cells, expressed in arbitrary units, mean + SEM. B. Cardiomyocytes from
the same experiment using mitosox red readout. C. Cardiomyocytes from the same experiment using TMRM readout. For all panels, means are significantly
different by ANOVA, * = sig different from control by Dunnett post-hoc test. PA = palmitate 200 μM, gp = gp91ds peptide 50 μM, Go = Go6983 5 μM,
LY = LY333531 50 nM, Cre = cresol 3 μM, PMA 100 nM.
doi:10.1371/journal.pone.0145750.g006
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in mitochondrial inner membrane potential. This demonstrates that the abnormalities induced
by palmitate are similar to the abnormalities induced by partially blocking the electron trans-
port chain. The fact that the NOX2 inhibitor peptide had only a minor effect on the reduction
in mitochondrial inner membrane potential is consistent with the direct effect of antimycin-A
on the electron transport chain. These findings also demonstrate that a reduction in mitochon-
drial inner membrane potential is not necessarily associated with a significant increase in ROS,
if NOX2 is inhibited.
Discussion
Our findings advance the understanding of cardiac biology by demonstrating that a physiologic
level of saturated fat inhibit mitochondrial oxidative phosphorylation and cause ROS in cardio-
myocytes. Palmitate causes mitochondrial ROS that is amplified by PKC-NOX2 activation,
leading to abnormal calcium homeostasis (Fig 8). By using pharmacologic inhibition of NOX2
and cardiomyocytes from NOX2 KOmice, we show that NOX2 has a central role in the gener-
ation of ROS caused by saturated fat. Furthermore, our studies identify a molecular mechanism
by which saturated fats can promote heart failure and arrhythmia.
Palmitate, mitochondria, and the heart
Although cardiac mitochondria have been the focus of scientific research for decades, much
less is known about mitochondrial fatty-acid metabolism and ROS generation in intact cardio-
myocytes. By using intact cells, we have been able to study cellular pathways that would be dis-
turbed in permeabilized cells or purified mitochondrial preparations. Palmitate is a normal
part of the human diet, yet there is strong evidence that it can cause multiple abnormalities.
High doses of palmitate can induce apoptosis in vitro [44, 45]. Palmitate-induced ROS has also
been implicated in insulin resistance [23]. Our data, showing a decrease in maximum oxidative
phosphorylation, in combination with decreased inner membrane potential, is consistent with
palmitate acting as a partial inhibitor of the electron transport chain. Direct measures of mito-
chondrial complex activity support this mechanism. Using the isolated cardiomyocytes model
system, we show that partial inhibition of the electron transport chain causes abnormalities
that are similar to palmitate, supporting this mode of action. These mitochondrial abnormali-
ties may contribute to the increased risk of heart failure arrhythmia in obese and diabetic
patients, since these diseases cause cardiac lipid overload.
Fig 7. Blocking electron transport chain with antimycin-A causes ROS andmitochondrial
depolarization. A. Representative experiment done with cardiomyocytes in triplicate, height is DCF
fluorescence minus background, in live cells, mean + SEM expressed in arbitrary units. B. Cardiomyocytes
from the same experiment using mitosox red readout. C. Cardiomyocytes from the same experiment using
TMRM signal. For all panels, means are significantly different by ANOVA, * = sig different from control by
post-hoc test. gp = gp91ds peptide 50 μM, AA = antimycin-A at 10, 20 or 40 μM.
doi:10.1371/journal.pone.0145750.g007
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PKC, NOX, and ROS
It is possible that palmitate can cause low-level activation of PKC directly, which leads to
NOX2 activation. However, the experiments with etomoxir, shown in Fig 4, indicate that full
activation of PKC requires palmitate to enter the mitochondria. We postulate that palmitate
initially causes a small amount of mitochondrial ROS. This activates NOX2 via PKC, generat-
ing more ROS, which causes more mitochondrial dysfunction in a feed-forward cycle. In vas-
cular tissue, there is cross talk between mitochondrial ROS and NOX, such that the one can
amplify the other [38]. ROS-induced ROS release (RIRR) has been shown to occur in cardio-
myocytes using stimulation such as photo-induced oxidation [46] and in Langendorff prepara-
tions perfused with H2O2 [39]. The molecular pathways responsible for RIRR in the heart have
not been identified. We demonstrate that is critical for amplifying mitochondrial ROS in cardi-
omyocytes, and thus NOX2 is a critical component of RIRR in this model system. The role of
NOX enzymes in cardiac pathology is complex [47]. Low-level NOX activity may be beneficial
and generate ROS as signaling intermediates. However, NOX activity is increased in human
heart failure [48] and NOX2 is activated in the atria of patients with atrial fibrillation and large
animal models of atrial fibrillation [49, 50]. Chronic activation of NOX2 by saturated fat could
promote heart failure and arrhythmia.
We also show that NOX2 is required for ROS generation caused by PKC activation in cardi-
omyocytes. Further, we show that activating endogenous PKC in cardiomyocytes is sufficient
to trigger NOX2-mediated ROS generation that in turn causes an increase in mitochondrial
ROS. Our experiments identify NOX2 as the major mediator of PKC induced ROS in cardio-
myocytes. Activation of conventional PKC isoforms has been implicated as a major factor in
heart failure pathophysiology [51]. Additional work will be necessary to determine if of PKC’s
harmful effects are mediated by NOX2-generated ROS in other disease states.
Abnormal calcium homeostasis
The observation that saturated fat increases calcium sparks is novel. The interaction between
NOX2 and RyR2 has been described previously, and accounts for increased sarcoplasmic retic-
ulum release with myocytes stretch [52]. This interaction was not previously known to have a
Fig 8. Diagram of proposed pathway. Saturated fats are internalized by cardiomyocytes and transported to
the mitochondria to be used as a fuel source for beta-oxidation, causing a low level of mitochondrial ROS.
This activates PKC, which in turn activates NOX2. ROS from NOX2 and mitochondrial ROS amplify each
other in a feed-forward cycle that promotes greater ROS production and sarcoplasmic reticulum (SR) calcium
leak.
doi:10.1371/journal.pone.0145750.g008
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role in mitochondrial metabolic abnormalities. Our findings indicate that palmitate causes
mitochondrial calcium overload due to increased sarcoplasmic reticulum leak from RyR chan-
nels. Since cardiac mitochondria are physically connected to the sarcoplasmic reticulum, and
mitochondria take up calcium released from the sarcoplasmic reticulum [53], it is plausible
that abnormal calcium release induced by palmitate could initiate mitochondrial dysfunction
in cardiomyocytes. Inhibition of RyR calcium release prevents ROS production by preventing
mitochondrial calcium overload and dysfunction. Our experiments with cresol demonstrate
that increased sarcoplasmic reticulum leak is sufficient to trigger mitochondrial ROS. These
results give us mechanistic insight into the cardiac biology that connects lipid overload to
abnormal calcium homeostasis and mitochondrial function.
We conclude that, in adult cardiomyocytes, palmitate induces ROS by a mechanism that
requires mitochondrial uptake and beta-oxidation of palmitate, and the mitochondrial ROS is
amplified by PKC-NOX2 activation. Activating this pathway results in increased sarcoplasmic
reticulum calcium leak, mitochondrial calcium overload, and mitochondrial dysfunction. Phar-
macologic NOX2 inhibition prevents the abnormalities caused by saturated fat. The mecha-
nisms revealed by this work may have therapeutic implication for heart disease caused by
diabetes and obesity. Although clinical trials of antioxidants for cardiovascular disease have
been disappointing, for the most part, there is some clinical evidence supporting beneficial
effects on heart rhythm [54–56]. It may be that antioxidants are only beneficial in certain
forms of cardiovascular disease, where increased ROS has a central role in the pathophysiology.
Pharmacotherapy that specifically targets the source of ROS could be more effective. NOX2
inhibition may be a potential therapy for heart rhythm abnormalities in obese and diabetic
patients. In addition, since increased RyR calcium leak is an important mechanism in heart fail-
ure [57], it is possible that NOX2 inhibition could be used as a treatment for heart failure.
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